Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. we hope you enjoy reading it.

1. India’s Department of Pharmaceuticals (DoP) has reportedly issued a communication to all pharmaceutical associations directing them to comply with the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. As per the directive, companies must submit a self-declaration and marketing expenditure disclosure for the financial year 2024–25 by 31st July 2025
Source: bit.ly/4jvX8Xq

2. The Ministry of Commerce and Industry authorised Ayushexcil, the Ayush Export Promotion Council under Appendix 2E of Foreign Trade Policy 2023 to issue non-preferential Certificates of Origin for Ayush products, streamlining exports and boosting global trade.
Source: bit.ly/4dM0fsZ

3. India’s pharmaceutical sector is expected to remain stable despite the U.S. Executive Order introducing a “Most Favoured Nation” pricing model, which seeks to cut branded drug prices by 30–80% by aligning them with the lowest OECD country prices. CRISIL Ratings reports that strong domestic demand and a focus on generics will help India’s pharma industry withstand these pricing pressures.
Source: bit.ly/45Lwd6y

4. India launches International Biomed Cross (IBC) to create a global network of biomedical engineers for rapid repair, maintenance, and remote support of critical medical equipment during health emergencies and disasters, ensuring uninterrupted healthcare services in underserved and crisis-affected regions.
Source: bit.ly/45Lwd6y

5. The U.S. President Trump has reportedly revoked a Biden-era policy under the Emergency Medical Treatment and Labor Act (EMTALA), 1986 that required hospitals to provide emergency abortions, even in states with abortion bans. This move creates legal uncertainty for hospitals and may limit emergency abortion care for pregnant women.
Source: bit.ly/4mMt1xF

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. we hope you enjoy reading it.

1. India’s Central Consumer Protection Authority (CCPA) has issued notices to popular e-commerce platforms for selling walkie-talkies without mandatory disclosures such as operating frequencies, licensing requirements, or Equipment Type Approval. This violates the E-commerce Rules and misleads consumers into believing these wireless devices can be freely operated without regulatory clearance.
Source: bit.ly/42RYUx2

2. The Government of India has directed the Department of Pharmaceuticals, along with the National Health Systems Resource Centre (NHSRC), to identify essential drugs, enhance their availability, and implement price controls to ensure affordability aiming to mitigate combat-related health risks during the ongoing conflict.
Source: bit.ly/4jQwcm9

3. Music companies are taking legal action against influencers for using copyrighted songs commercially in paid social media posts without proper permission or licenses. According to a popular social media platform policy, licensed music is allowed only for personal, non-commercial use and not for branded content.
Source: bit.ly/3GOLxoK

4. US President is reportedly set to bring an executive order that seeks to cut prescription drug prices by using global benchmarks and bringing in “most favored nation” pricing into play. The U.S. will match the lowest price paid by any nation, potentially impacting Indian exporters’ profit margins.
Source: bit.ly/43kJiBk

5. India and the UK have finalized a free trade agreement, where India has agreed to reduce import duties on the British products, including Scotch whisky, gin, and cars. However, India is protecting its farmers and local producers by maintaining duties on sensitive agricultural items like dairy, apples, cheese, and oats.
Source: bit.ly/3GK4bOG